Corcept therapeutics exec sells $509k in stock, buys options By Investing.com
In one of the recent deals, Gary Charles Robb, Chief Business Officer at... Corcept Treatments (NASDAQ:), sold shares of the company's common stock for a total value of approximately $509,080. The sale, dated October 1, 2024,…
